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Hyperactivity of mTORC1, a key mediator of cell
growth, leads to stem cell depletion, although the
underlying mechanisms are poorly defined. Using
spermatogonial progenitor cells (SPCs) as a model
system, we show that mTORC1 impairs stem cell
maintenance by a negative feedback from mTORC1
to receptors required to transduce niche-derived
signals. We find that SPCs lacking Plzf, a transcrip-
tion factor essential for SPC maintenance, have
enhanced mTORC1 activity. Aberrant mTORC1 acti-
vation in Plzf / SPCs inhibits their response to
GDNF, a growth factor critical for SPC self-renewal,
via negative feedback at the level of the GDNF
receptor. Plzf opposes mTORC1 activity by inducing
expression of themTORC1 inhibitor Redd1. Thus, we
identify the mTORC1-Plzf functional interaction as
a critical rheostat for maintenance of the spermato-
gonial pool and propose a model whereby negative
feedback from mTORC1 to the GDNF receptor
balances SPC growth with self-renewal.
INTRODUCTION
Maintenance of a wide array of adult tissues is dependent on the
presence of a resident stem cell pool with self-renewal potential
that generates differentiating progeny. Factors regulating the
balance between stem cell self-renewal and differentiation
ensure tissue homeostasis whereas disruption of these regula-
tory mechanisms can lead to tissue degeneration or cancer (Ito
et al., 2009). One factor central to stem cell homeostasis is
mammalian TOR complex 1 (mTORC1), a signaling complex
that promotes protein translation and cell growth by phosphory-
lating components of the translation machinery (Ma and Blenis,
2009). mTORC1 is regulated in response to diverse stimuli
including nutrient availability, energy status, growth factors,
and cellular stress. Persistent mTORC1 activation in certain
tissues leads to increased proliferation but subsequent exhaus-
tion of the stem cell compartment, demonstrating that aberrantly468 Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc.activated mTORC1 is detrimental to stem cell maintenance
(Castilho et al., 2009; Gan and DePinho, 2009; Yilmaz et al.,
2006). It is proposed that inappropriate mTORC1 activation
drives stem cell depletion through aberrant translation of down-
stream targets and subsequent activation of tumor suppressive/
fail-safe mechanisms resulting in cellular senescence or apo-
ptosis (Ito et al., 2009). However, the molecular mechanisms
and targets of mTORC1 in this context are currently unknown.
Interestingly, inhibition of mTORC1 also extends organism life-
span (Harrison et al., 2009; Schieke and Finkel, 2006), consistent
with the notion that declining stem cell potential underlies aging
(Rossi et al., 2008).
Undifferentiated germline cells of the testis (spermatogonial
progenitor cells; SPCs) are formed from gonocytes during post-
natal development of the mouse testis and possess self-renewal
potential (de Rooij and Russell, 2000). A major advance in the
study of male germline biology was the development of culture
systems allowing long-term SPC expansion in vitro while main-
taining stem cell potential. Key to this was the observation that
mice heterozygous for the glial cell-derived neurotrophic factor
(GDNF) cytokine gene had a depletion of SPC activity (Meng
et al., 2000). GDNF is produced by Sertoli cells within the testis,
and signals via the GFRa1/c-Ret receptor to promote SPC self-
renewal and growth through activation of Src family kinases and
Akt (Lee et al., 2007b; Oatley et al., 2007). Culture of SPCs with
GDNF plus a variety of additional factors (including basic fibro-
blast growth factor; bFGF) preserves self-renewal capabilities
and allows essentially unlimited cell expansion while maintaining
in vivo differentiation potential; assessed by the ability to repopu-
late depleted recipient testis (Kanatsu-Shinohara et al., 2003;
Kubota et al., 2004; Seandel et al., 2007). Although some cellular
signaling pathways involved in SPC self-renewal have been
described, it remains unclear how SPCs integrate signals from
general mitogenic stimuli with those required for self-renewal
to balance stem cell maintenance and differentiation.
A limited number of cell intrinsic factors have also been impli-
cated in SPC function, foremost among which is promyelocytic
leukemia zinc finger (PLZF). PLZF was identified from the trans-
location breakpoint in t(11;17) acute promyelocytic leukemia
(Chen et al., 1993) and encodes a transcription factor belonging
to the POZ-Kru¨ppel (POK) family. PLZF binds DNA through
carboxy-terminal Kru¨ppel-type zinc fingers and recruits histone
deacetylases (HDACs) via an amino-terminal POZ domain (David
et al., 1998). Recruitment of HDACs to target promoters can
result in gene repression although PLZF is also able to activate
gene expression (Doulatov et al., 2009; Labbaye et al., 2002).
Male mice lacking Plzf expression undergo progressive germ
cell loss and testis atrophy with age causing infertility (Buaas
et al., 2004; Costoya et al., 2004). Plzf is expressed by SPCs
and is needed in a cell autonomous fashion for maintenance
of the germ lineage. A male patient with biallelic PLZF loss-of-
function and gonad hypoplasia has been recently reported
(Fischer et al., 2008), emphasizing the role played by PLZF in
germ cell biology.
SPC maintenance is dependent on Plzf plus key growth
factors such as GDNF. As mTORC1 is activated in response to
growth factor signaling we hypothesized that both Plzf and
mTORC1 are involved in the GDNF response of SPCs and that
Plzf and mTORC1 may crosstalk. To assess the roles of Plzf
and mTORC1 in GDNF-dependent SPCmaintenance, we devel-
oped systems for isolation and culture of SPCs from wild-type
(WT) and Plzf / prepubertal mice (subsequent to formation
of the SPC pool and prior to overt germ cell depletion in the
Plzf / mouse). We find that Plzf opposes mTORC1 activity
and define a cellular signaling network controlling SPC homeo-
stasis whereby mTORC1 integrates mitogenic signals received
by SPCs and determines their sensitivity to self-renewal stimuli.
RESULTS
Isolation, Culture, and Comparative Analysis
of Plzf +/+ and Plzf / SPCs
The testis is composed of a heterogeneous mix of mitotic and
meiotic germ cells plus multiple types of somatic cells. SPCs
are rare within the testis and systems for their purification are
poorly developed. We therefore sought to take advantage of
the expression of Plzf in SPCs to enrich for this cell type. Plzf-
expressing cells were identified from juvenile testis by intracel-
lular staining and flow cytometry using a newly developed
monoclonal antibody (Figure 1A). Our aim was to correlate the
Plzf-expressing population to sets of cell surface markers that
would allow subsequent purification of those live cells. By adapt-
ing markers able to enrich for stem cell activity from cryptorchid
testis (Kubota et al., 2003; Shinohara et al., 2000), we found
that the Plzf-positive population was av-integrin negative and
expressed low levels of Thy-1 (Figure 1B). Negative selection
for av-integrin combined with Thy-1 positive selection allowed
isolation of Plzf-positive cells and minimized somatic cell
contamination (Figures S1A and S1B available online) (Virtanen
et al., 1986). c-Kit expression is associated with SPC differentia-
tion (Schrans-Stassen et al., 1999) and the avneg Thy-1low popu-
lation was composed primarily of c-Kit negative cells with
a smaller c-Kit positive fraction (Figure 1C, left). The c-Kitneg cells
were largely in G1/G0 phase of cell cycle whereas the c-Kit
pos
population contained more cells in S plus G2 phases (Figure 1C,
right). As SPCs are more quiescent than differentiating sper-
matogonia (Takubo et al., 2008), the avneg Thy-1low population
contains both SPCs (c-Kitneg, quiescent) and cells undergoing
differentiation (c-Kitpos, proliferating). To confirm that the avneg
Thy-1low c-Kitneg fraction was enriched for stem cells, wecompared the ability of avneg Thy-1low c-Kitneg and unfractio-
nated cells to repopulate recipient depleted testis (Ogawa
et al., 1997). Donor cells were isolated from transgenic mice
expressing GFP from the b-actin promoter, allowing visualization
of donor-derived colonies (Figure 1D, left). Numbers of GFP-
positive colonies were scored 2 months posttransplant (Fig-
ure 1D, right), representing numbers of engrafted stem cells.
Stem cell activity was enriched 25-fold in the avneg Thy-1low
c-Kitneg population compared to unfractionated cells. As the
avneg Thy-1low c-Kitneg fraction represents 3%–5% of total
cells (1/25th of testis cellularity) from 10 to 14 days postnatal
testis (Figures 1B, 1C, and 1G), a 25-fold enrichment of stem
cell activity indicates that almost all stem cells are contained
within this fraction. Given the number of colonies obtained
from avneg Thy-1low c-Kitneg cells (Figure 1D) and an estimated
10% engraftment efficiency (Nagano et al., 1999), there are
1265 stem cells per 105 cells in this fraction (1 in 80 cells
have stem cell potential).
We next analyzed prepubertal Plzf +/+ and Plzf / testis by
flow-cytometry to determine if Plzf / mice display aberrant
SPC activity before overt germ cell depletion. Although the char-
acteristic av/Thy-1 flow profile was present in juvenile Plzf /
testis (2 and 3 weeks postnatal), the avneg Thy-1low population
was depleted relative to the WT (Figure 1E and Figure S1C)
and the percentage of c-Kitpos cells within the Plzf / avneg
Thy-1low fraction was increased (Figure 1F and Figure S1D).
The decreased frequency and numbers of avneg Thy-1low c-Kitneg
cells in Plzf / testis (Figure 1G) confirms that Plzf loss is detri-
mental to SPCs whereas the increase in c-Kitpos cells within the
avneg Thy-1low fraction is suggestive of increased differentiation
commitment. As Plzf directly represses c-Kit expression
(Filipponi et al., 2007), this can be reflective of a de-repression
of the c-Kit locus. However, the Plzf / avneg Thy-1low fraction
still contains c-Kitneg cells (Figure 1F and Figure S1D), indicating
that aberrant c-Kit expression is unlikely to fully explain the
Plzf / phenotype. Additionally, both Plzf +/+ and Plzf / avneg
Thy-1low c-Kitneg cells show substantial enrichment in expres-
sion of the SPC-associated factors Pou5f1/Oct4, Ngn3, Bcl6b,
and Pou3f1 (Figure 1H and Figure S1E) (Oatley et al., 2006;
Ohbo et al., 2003; Wu et al., 2010; Yoshida et al., 2006), confirm-
ing the identity of this fraction. We also noted that Plzf / avneg
Thy-1low cells had decreased levels of b1 and a6 integrins but
equivalent levels of CD9 compared to controls (Figures S1F
and S1G) (Kanatsu-Shinohara et al., 2004b; Shinohara et al.,
1999). Our data indicate that SPCs from juvenile Plzf / mice
have an impaired ability to maintain an undifferentiated state,
which precedes overt germ cell loss.
We next attempted in vitro culture of isolated Plzf +/+ and
Plzf / SPCs, adapting previously developed culture systems
(Kubota et al., 2004; Seandel et al., 2007). As anticipated, germ
cell colony-forming activity under SPC culture conditions was
essentially entirely contained within the avneg Thy-1low fraction
(Figure S2A). We successfully derived SPC lines from both
Plzf +/+ and Plzf / avneg Thy-1low cells, which grew as discrete
colonies on mouse embryonic fibroblast (MEF) feeder cells
(Figure 2A) and maintained their cell surface marker identity
during exponential growth over 1 year of culture (Figure S2B).
WT SPC lines expressed Plzf (Figure 2B) whereas Plzf / SPCCell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc. 469
Figure 1. Isolation and Analysis of Plzf +/+
and Plzf / SPCs
(A) Detection of Plzf-expressing spermatogonia
from juvenile testis (10–14 days postnatal) by intra-
cellular staining and flow cytometry using anti-Plzf
antibody.
(B) Plzf expressing cells correlate to a discrete av-
integrin negative, Thy-1 low population by flow cy-
tometry. CD45 marker excludes contaminating
leukocytes.
(C) Left panel: flow cytometric analysis of c-Kit
within the Plzf-expressing av-integrin negative,
Thy-1 low population. Right panels: cell cycle
status of c-Kit negative and positive populations
plus percentage of cells in G1/S/G2 cell cycle
phases from a representative sample.
(D) Left panels: seminiferous tubules repopulated
with donor GFP-positive av integrin negative,
Thy-1 low, c-Kit negative cells in testis transplant
assay. Fluorescent image (top) and brightfield
image of same recipient testis (bottom) are shown.
Right panel: numbers of GFP positive colonies ob-
tained from av integrin negative, Thy-1 low, c-Kit
negative (sorted) and unsorted testis cells in recip-
ient testes 2 months posttransplant. Data is pre-
sented as mean number of colonies per 1 3 105
donor cells together with standard error of the
mean (SEM). Fold enrichment of stem cell activity
in sorted populations is indicated (***p < 0.0001).
Values are averaged from two independent exper-
iments. Thirteen recipient testes were analyzed for
sorted populations and 12 for unsorted.
(E) Representative av-integrin/Thy-1 flow profiles
of Plzf +/+ and Plzf / littermate mouse testes at
2 weeks postnatal age. The av-integrin negative,
Thy-1 low gate, containing Plzf-positive cells in
WT testis is indicated.
(F) Representative flow cytometry analysis of c-Kit
expression within the av-integrin negative, Thy-1
low testis cell fractions from (E).
(G) Quantification of frequency and absolute
numbers of av integrin negative, Thy-1 low, c-Kit
negative testis cells from mice of the indicated
postnatal ages andPlzf genotypes (n = 3 per geno-
type and age group, **p < 0.002, *p < 0.02).Graphs
represent mean values ± SEM.
(H) Quantitative RT-PCR analysis of Pou5f1 mRNA
expression in testis cell populations from juvenile
Plzf +/+ and Plzf / littermate mice: total (unfrac-
tionated testis cells), SPCs (av-integrin negative, Thy-1 low, c-Kit negative), early differentiating spermatogonia (av-integrin negative, Thy-1 low, c-Kit positive),
late differentiating spermatogonia (av-integrin negative, Thy-1 negative, c-Kit positive), and somatic cells (av-integrin positive). mRNA levels are normalized to
those of b-actin and standard deviations from duplicate reactions are shown.
See also Figure S1.lines were more difficult to establish (not shown) consistent with
a role for Plzf in SPC function. Early passages of Plzf / SPCs
had a slower growth rate than WT cells (Figures S2C and S2D)
but could be maintained long-term and growth became more
comparable to WT cells at later passages (Figure 5C). The ability
to culture Plzf / SPCs seemed counterintuitive, but the gener-
ation of these cultures became critical for further dissection of
Plzf function and to the solution of this apparent contradiction.
An additional indicator of SPC potential is the ability to derive
embryonic stem-like cells from the cultured lines (multipotent
adult spermatogonial-derived stem cells; MASCs) (Kanatsu-470 Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc.Shinohara et al., 2004a; Seandel et al., 2007). We observed
spontaneous formation of MASC colonies from two of seven
WT lines (Figure S2E). MASC formation was not observed in
four Plzf / SPC lines, possibly indicating a defective capability
to generate MASCs. The multipotent capabilities of MASC lines
were verified by teratoma formation assay (Figure S2F). On SPC
to MASC conversion, expression of the pluripotency-associated
factors Pou5f1/Oct4, Sox2 and Nanog were substantially
increased whereas Plzf expression was lost (Figure S2G and
data not shown) (Seandel et al., 2007). Formation of MASCs indi-
cates that SPC potential is maintained in our culture system,
Figure 2. Increased mTORC1 Pathway
Activity in Plzf / SPCs
(A) SPC lines established from culture of av-integ-
rin negative, Thy-1 low cells from juvenile Plzf +/+
and Plzf / littermate mice immunostained for
the germ cell marker Mvh and counterstained
with DAPI to detect DNA. Scale bar represents
100 mm.
(B) Cultured SPCs of the indicated genotype
analyzed for Plzf expression by intracellular stain-
ing and flow cytometry (left panel) and by western
blot (right panel). The germ cell marker Mvh plus
actin are used as loading controls.
(C) Analysis of SPC size by flow cytometry.
Forward-scatter (FSC) profiles of two indepen-
dently derived sets of littermate Plzf +/+ and
Plzf / SPC lines (1 and 2) are shown.
(D) Quantification of flow cytometry profiles from
(C) showing averaged mean FSC with standard
deviation and p value.
(E) Control (DMSO) and rapamycin-treated Plzf +/+
and Plzf / SPCs were fixed and permeabilized
48 hr post-treatment and levels of Phospho-
RPS6 analyzed by flow cytometry.
(F) Normalization of increased Plzf / SPC size by
mTORC1 inhibition. FSC profiles of Plzf / SPCs
treated with DMSO (control) or rapamycin for
48 hr compared to untreated Plzf +/+ SPCs.
(G) Overlay of representative av-integrin negative,
Thy-1 low, c-Kit negative testis cell fraction FSC
profiles from Plzf +/+ and Plzf / littermate mice
treated from 10 days postnatal age for a period
of 1 week with vehicle or rapamycin.
(H) Quantification of relative mean FSC values of
av-integrin negative, Thy-1 low, c-Kit negative
testis cells ofmice treated as in (G) (n = 4 per geno-
type and treatment group, *p < 0.05, **p < 0.01).
Horizontal bars represent mean values.
See also Figure S2.whereas the apparent inability of Plzf / SPCs to form MASCs
can be consistent with their defective function.
Plzf / SPCs Show Enhanced mTORC1 Activity
From analysis of cultured SPC lines, we noticed thatPlzf / cells
were physically larger than WT SPCs, measured by the FSC
parameter of flow cytometry (Figures 2C and 2D). Alterations in
cell size are associated with changes in activity of mTORC1
acting through its downstream targets S6Kinase1 (S6K1), which
phosphorylates ribosomal S6 protein (RPS6), and 4EBP1 (Fingar
et al., 2002; Ruvinsky et al., 2005). Given the role of mTORC1 in
hematopoietic stem cells (Gan and DePinho, 2009), we consid-
ered that aberrant mTORC1 activity in Plzf / SPCs could
contribute to their defective maintenance. Importantly, Plzf /
SPCs had elevated levels of phosphorylated RPS6 compared
to WT cells, confirming increased mTORC1 activity (Figure 2E
and Figure 3C). Inhibition of mTORC1 with rapamycin decreased
the size of Plzf / SPCs to that of WT cells suggesting thatelevated mTORC1 activity was responsible for the size increase
(Figure 2F). Rapamycin was confirmed to inhibit RPS6 phos-
phorylation in Plzf / SPCs (Figure 2E). Increased mTORC1
activity in Plzf / SPCs was associated with elevated levels of
cellular protein (Figure S2H), consistent with the role of mTORC1
in regulating protein translation. Importantly, freshly isolated
Plzf / SPCs were also physically larger (Figures 2G and 2H)
and rapamycin treatment of Plzf / mice normalized SPC size
(Figures 2G and 2H). Together, our data indicate that Plzf inhibits
mTORC1 activation in SPCs.
Growth Factor-Mediated Regulation ofmTORC1 in SPCs
Given the possibility that mTORC1 activity can regulate SPC
function, we next defined key regulatory inputs of mTORC1 in
WT SPCs. Growth factor signaling represents a major activating
input of mTORC1 (Ma and Blenis, 2009; Shaw and Cantley,
2006) and mTORC1 inhibition interferes with mitogenic stimuli
causing cell cycle arrest (Brown et al., 1994). Indeed, rapamycinCell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc. 471
Figure 3. Upstream Pathways and Growth Factors
Regulating mTORC1 in SPCs
(A) WT SPCs fed with complete SPC medium containing
inhibitors to the indicated signaling pathways were har-
vested 5 hr after treatment and analyzed by western blot
for the indicated proteins and phospho (P)-proteins.
(B) WT SPCs were starved overnight in basal SPCmedium
lacking cytokine supplements. The indicated cytokines
were then added and SPCs harvested 20 min later then
analyzed by western blot. Cytokines were used at the
concentrations present in complete SPC medium. Neure-
gulin1 (NRG1) is not a standard supplement for SPC
medium although SPCs are responsive to it (see text).
(C) Western blot analysis of two independently derived
sets of littermate Plzf +/+ and Plzf / SPC lines (1 and 2)
under steady-state conditions is shown to the left. Quanti-
fication of the relative levels of phospho-Akt, Erk, and
RPS6 (corrected to the total levels of respective proteins)
are shown in panels on the right.
See also Figure S3.suppressed SPC colony growth and caused an accumulation of
cells in G1 phase of the cell cycle (Figures S3A and S3B).
Growth factor receptors activate mTORC1 by signaling
through phosphoinositide 3-kinase (PI3K)/Akt and Ras/Erk
MAPK, which inhibit the TSC1/TSC2 complex (Huang and
Manning, 2008); TSC1/TSC2 negatively regulates mTORC1 via
its GTPase-activating protein activity toward the small G protein
Rheb. Treatment of WT SPCs with PI3K/Akt or Erk MAPK
pathway inhibitors significantly reduced levels of phosphory-
lated RPS6 (Figure 3A), indicating that efficient mTORC1 activa-
tion in SPCs requires both PI3K/Akt and Erk MAPK. Inhibition of
Src family kinases, implicated in the GDNF response of SPCs
(Oatley et al., 2007), had modest effects on phospho-RPS6
(Figure 3A). Therefore, despite the ability of Src family kinases
to activate PI3K/Akt downstream GDNF (Encinas et al., 2001;
Oatley et al., 2007), this SPC self-renewal pathway couples inef-
ficiently to mTORC1.
SPCs are maintained with a cocktail of growth factors
(Kanatsu-Shinohara et al., 2003; Seandel et al., 2007) and are
responsive to others (Hamra et al., 2007); thus we next assessed
contributions of these factors to mTORC1 activation in WT
SPCs. We found that GDNF triggered a modest phosphorylation
of RPS6whereas othermitogens (including bFGF) inducedmuch472 Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc.higher levels of phospho-RPS6 (Figure 3B). The
relative abilities of GDNF and bFGF to activate
mTORC1 correlated to their efficiency of Akt
and Erk activation (Figure 3B). However, this
correlation did not hold true for epidermal
growth factor (EGF) stimulation, possibly re-
flecting additional pathways by which EGF acti-
vates mTORC1 (Fan et al., 2009). In summary,
the self-renewal signal GDNF poorly activates
mTORC1 when compared to more general
mitogens for SPCs (bFGF, EGF), in agreement
with the Src kinase inhibition data (see above).
However, we note that although GDNF is
considered the key SPC self-renewal signal,SPC expansion and self-renewal in vitro requires a combination
of GDNF plus other factors (e.g., bFGF) that stimulate mTORC1
more efficiently (Lee et al., 2007b).
Plzf Uncouples mTORC1 Activity from Growth Factor
Signaling in SPCs through Redd1 Modulation
Given that mTORC1 activity in SPCs is regulated by growth
factors present in the culture medium and resultant PI3K/Akt
and Erk-MAPK activation, we next assessed whether the
elevated mTORC1 activity of Plzf / SPCs correlated with an
enhanced growth factor response. However, in comparison to
WT cells, the Akt and Erk activities of steady-state Plzf /
SPCs were decreased whereas phospho-RPS6 was increased
(Figure 3C), indicating that the elevated mTORC1 activity is not
due to increased activity of growth factor pathways.
We next considered alternative mechanisms by which
mTORC1 activity would be increased in Plzf / SPCs. Cellular
stress-response pathways provide additional regulatory inputs
resulting in mTORC1 inhibition when conditions such as low
energy availability or hypoxia require temporary arrest of cell
growth (Huang and Manning, 2008). We hypothesized that
mTORC1 hyperactivity in Plzf / SPCs could be due to reduced
activity of stress response pathways. Accordingly, we first
Figure 4. Plzf Regulates Expression of the
mTORC1 Pathway Inhibitor Redd1
(A) Western blot analysis for components of the
mTORC1 pathway in two independently derived
sets of littermate Plzf +/+ and Plzf / SPC lines
(1 and 2) under steady-state conditions.
(B) Quantitative RT-PCR analysis of Redd1 mRNA
expression in independently derived Plzf +/+ and
Plzf / SPC lines. mRNA levels are normalized
to those of b-actin and standard deviations from
duplicate reactions are shown.
(C) Quantitative RT-PCR analysis of Redd1 mRNA
expression in spermatogonial fractions from
juvenile Plzf +/+ and Plzf / littermate mice:
SPCs (av-integrin negative, Thy-1 low, c-Kit nega-
tive), early differentiating spermatogonia (av-
integrin negative, Thy-1 low, c-Kit positive), late
differentiating spermatogonia (av-integrin nega-
tive, Thy-1 negative, c-Kit positive). mRNA levels
are normalized to those of b-actin and standard
deviations from duplicate reactions are shown.
Dashed line indicates Redd1 expression levels in
unfractionated WT testis cells.
(D) WT SPCs infected with control shRNA (against
GFP) or two independent shRNA constructs
against Redd1 were analyzed by western blot for
the indicated proteins. Quantification of relative
levels of phospho-RPS6 (corrected to total RPS6
levels) is shown under respective lanes. Cells
were under steady-state culturing conditions
(see also Figure S4).
(E) Top panel: Redd1 promoter (from translation
start site at +1 to 2 kb upstream) with location of
previously described transcription factor binding
sites. The promoter is divided into proximal and
distal regions (PP and DP, respectively). Positions
of ChIP amplicons are indicated. Bottom panel:
ChIP assay. Quantitative PCR for Redd1 promoter
regions from WT SPC chromatin pulled down
with Plzf antibody. Fold enrichment is shown rela-
tive to background of chromatin pulled down from
Plzf / SPCs with the same antibody. Standard
deviations from duplicate PCR reactions are
indicated.
(F) Luciferase reporter assay with constructs con-
taining the PP+DP Redd1 promoter regions or PP
alone. 293HEK cells were transfected with the
appropriate luciferase reporter together with PLZF constructs or vector control as indicated. Reporter activities were normalized to that of TK-Renilla and empty
vector luciferase reporter controls (*p < 0.001). Mean values from triplicate wells and associated standard deviations are indicated.assessed levels of upstream regulatory proteins as stress
pathways converge on mTORC1 at the level of TSC1/TSC2.
However, we did not find significant differences in levels of
Tsc1, Tsc2, Rheb, or the mTOR kinase itself in Plzf / SPCs
compared to WT cells (Figure 4A).
By contrast, we noticed that levels of Redd1 (also known as
Ddit4, Rtp801, and Dig2) were substantially lower in Plzf /
SPCs compared to controls, at both protein and mRNA levels
(Figures 4A and 4B). Redd1 is induced by multiple types of cell
stress (e.g., hypoxia, DNA damage) and by developmental
signals and inhibits mTORC1 through regulation of TSC1/TSC2
(Brugarolas et al., 2004; Corradetti et al., 2005; Ellisen et al.,
2002). As a role for Redd1 in SPCs is not described, we analyzed
the distribution of Redd1 expression in isolated spermatogonialfractions and found a relative enrichment of Redd1 mRNA
in SPCs (Figure 4C). We also confirmed that freshly isolated
Plzf /SPCs had lowerRedd1 expression compared to controls
(Figure 4C). Furthermore, shRNA knockdown of Redd1 in WT
SPCs increased mTORC1 activity (Figure 4D and Figure S4).
Together, our data suggest that Plzf opposes mTORC1 by main-
taining Redd1 expression and that Redd1 is a key mTORC1
regulator in SPCs.
Plzf Is a Transcriptional Activator of the mTORC1
Inhibitor Redd1 in SPCs
Redd1 expression was decreased at the mRNA level in
Plzf / SPCs. We therefore tested whether Plzf could directly
induce Redd1 expression. We first performed a chromatinCell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc. 473
Figure 5. A Negative Feedback Loop from
mTORC1 to the GDNF Receptor Is Activated
in Plzf / SPCs
(A) Plzf +/+ and Plzf / SPCs starved overnight in
basal SPC medium supplemented with DMSO
(vehicle control) or rapamycin were stimulated
with 10ng/ml GDNF for 20 min before harvesting
for western blot analysis.
(B) Quantification of relative levels of phospho-Akt
and phospho-RPS6 (corrected to total levels of
respective proteins) from (A).
(C) Plzf +/+ and Plzf / SPCs were plated in
medium containing decreasing concentrations of
GDNF, harvested one week later and counted to
determine fold cell recovery as an indicator of
growth. The concentration of GDNF was varied
from 4 ng/ml (left bars) to 1 ng/ml (right bars). Stan-
dard deviations from duplicate wells are indicated
(**p < 0.01, *p < 0.02).
(D) Quantitative RT-PCR analysis of GDNF
receptor components in Plzf +/+ and Plzf /
SPCs treated with DMSO (vehicle control) or rapa-
mycin for 48 hr. mRNA levels are normalized to
those of b-actin and standard deviations from
duplicate reactions are shown.
(E) Flow cytometry analysis of Gfra1 levels from
SPC lines treated as in (D).
(F) Quantitative RT-PCR analysis of GDNF
receptor components in av-integrin negative,
Thy-1 low, c-Kit negative testis cell fractions
pooled from 2-week-old Plzf +/+ and Plzf /
mice. mRNA levels are normalized to those of
b-actin and standard deviations from duplicate
reactions are shown.
See also Figure S5.immunoprecipitation (ChIP) assay to assess whether Plzf was
bound to the Redd1 promoter in SPCs. We scanned a 2-kb
region upstream Redd1 that contains binding sites for multiple
transcription factors known to regulate Redd1 expression
(Figure 4E) (Ellisen et al., 2002; Lin et al., 2005; Shoshani et al.,
2002). Importantly, we could detect Plzf association with distal
promoter (DP) regions but not proximal promoter (PP) regions
(Figure 4E), indicating that Plzf regulates Redd1 expression
through recruitment to the DP. To confirm this we performed
luciferase assays with REDD1 promoter constructs containing
both DP+PP elements and the PP element alone (Figure 4F).
In agreement with our ChIP results, PLZF activated the DP+PP
construct but not the PP construct. Further, deletion of the
PLZF POZ domain prevented PP+DP reporter activation, indi-
cating a requirement for this protein-protein interaction domain.
We conclude that Plzf directly activatesRedd1 through the DP to
inhibit mTORC1 in SPCs.
Active mTORC1 Inhibits SPC Self-Renewal Pathways
via a Negative Feedback Loop
As Plzf / SPCs show increased mTORC1 but decreased Akt
activities (Figure 3C), we considered that negative feedback474 Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc.from mTORC1 could prevent Plzf / cells from activating Akt
in response to growth factors. In cells lacking TSC1/TSC2,
increased mTORC1-signaling induces a negative feedback
loop from the mTORC1 downstream target S6K to upstream
signaling components causing inhibition of PI3K/Akt (Harrington
et al., 2004; Shah et al., 2004). Therefore, we tested whether
aberrant mTORC1 activity inhibited the response of Plzf /
SPCs to GDNF, a growth factor required for SPC self-renewal,
which could explain the maintenance defect of Plzf / SPCs.
We compared the response of starved Plzf +/+ and Plzf /
SPCs to GDNF in the absence or presence of rapamycin to
vary mTORC1 activity (Figures 5A and 5B). Consistent with
previous data, Plzf / SPCs showed lower levels of basal
and GDNF-stimulated Akt activity when compared to WT
SPCs, indicating a substantially reduced ability of Plzf / cells
to activate PI3K/Akt. However, on rapamycin treatment, the
ability of Plzf / SPCs to activate Akt in response to GDNF
was significantly increased and became comparable to that of
WT cells. This rescue of GDNF responsiveness by rapamycin
indicates that a negative feedback response from aberrantly
activated mTORC1 suppresses the response of Plzf / SPCs
to GDNF. Indeed, if GDNF levels in the media were reduced,
Plzf / SPC growth was inhibited more substantially than that of
the WT cells (Figure 5C). A decreased sensitivity to GDNF due
to negative feedback from mTORC1 can explain the defect in
Plzf / SPC maintenance in vivo when levels of GDNF are
limiting (Meng et al., 2000) and how Plzf / SPCs can be
cultured in vitro when GDNF is supplied to excess. Importantly,
GDNF expression in Plzf / testis was equivalent to that of
the WT (Figure S5), ruling out noncell autonomous defects in
production of niche factors.
Activated mTORC1 Suppresses Expression of GDNF
Receptor Components
We next sought to determine the mechanism by which activated
mTORC1 inhibits response of Plzf / SPCs to GDNF. Negative
feedback from mTORC1 to PI3K/Akt was originally character-
ized in the context of insulin responsiveness and signaling
through IRS1/2 proteins (Harrington et al., 2005). Although IRS
proteins have been implicated in activation of PI3K by the
GDNF receptor component c-Ret (Hennige et al., 2000), we
noticed that expression of the GDNF receptor components
GFRa1 and c-Ret in SPCs were responsive to rapamycin
(Figures 5D and 5E). Cultured Plzf / SPCs expressed lower
levels of GFRa1 and c-Ret compared to WT cells (correlating
with reduced GDNF-responsiveness) but on mTORC1 inhibition,
expression of these GDNF receptor components was increased
back to WT levels. Expression of GFRa1 and c-Ret were also
lower in freshly isolated Plzf / SPCs compared to WT SPCs
(Figure 5F), confirming that Plzf loss disrupts GDNF receptor
expression in vivo. Our data suggest that aberrantly activated
mTORC1 inhibits the response of Plzf / SPCs to GDNF by
opposing expression of the receptor. Interestingly, mTORC1
inhibits upstream signaling events in MEFs through transcrip-
tional inhibition of the PDGF receptor (Zhang et al., 2007). In
SPCs, negative feedback between mTORC1 and the GDNF
receptor will lead to loss of self-renewal whenmTORC1 is hyper-
activated, such as occurs on loss of Plzf expression (Figure S6A).
This feedback loop would inversely couple cell growth to self-
renewal, so that on expansion of the stem cell pool by mitogenic
stimulation and resultant mTORC1 activation, response of the
cells to self-renewal signals is inhibited, restricting stem cell
numbers. Interestingly, GDNF activates mTORC1 weakly in
SPCswhen compared to othermitogens (e.g., bFGF) (Figure 3B),
suggesting that GDNF would trigger a limited activation of the
negative feedback response whereas bFGF could cause more
extensive inhibition of GDNF signaling via mTORC1.
Rapamycin Treatment Attenuates the SPCMaintenance
Defect of Plzf / Mice and Increases SPCs in WT
Control Mice
As inhibition of aberrant mTORC1 activity in Plzf / SPCs in vitro
rescues their response to GDNF, we next asked whether
mTORC1 inhibition in vivo could rescue the Plzf / SPCmainte-
nance defect. We initiated rapamycin treatment of Plzf / and
WT control mice during early stages of postnatal development
(10 days postnatal) and continued daily treatment for 1 week,
a regimen able to normalize the increased size of Plzf / SPCs
(Figures 2G and 2H). Subsequent analysis of SPC compartment
status demonstrated that rapamycin increased both frequencyand numbers of avneg Thy-1low c-Kitneg cells in Plzf / testis,
approaching those values found in vehicle-treated WT controls
(Figures 6A and 6B). Rapamycin treatment of Plzf / mice
increased both the frequency of avneg Thy-1low cells and normal-
ized the increased percentage of c-Kitpos cells within this fraction
compared to controls (Figure 6A). We conclude that aberrant
mTORC1 activation can explain, at least in part, the SPCmainte-
nance defect of Plzf / mice.
Intriguingly, rapamycin also increased the frequency of SPCs
in WT mice (Figure 6B), suggesting that mTORC1 inhibition
stimulates SPC function in a WT setting. Indeed, in WT SPCs,
rapamycin enhanced Akt activation in response to GDNF
(Figures 5A and 5B) and increased GDNF receptor expression
(Figures 5D and 5E). Importantly, prolonged rapamycin treat-
ment of juvenile WT mice increased the number of cells with
high levels of Plzf expression in the testis (Figures 6C and 6D
and Figure S6B) and enhanced GDNF receptor expression
(Figure S6C), suggesting that physiological mTORC1 activity
controls size and function of the SPC pool in vivo.
DISCUSSION
Disruption of genes encoding for negative regulators of the PI3K/
Akt/mTORC1 pathway (e.g.,Pten, Tsc1, andPml) leads to loss of
hematopoietic stem cell (HSC) quiescence and subsequent
exhaustion. Rapamycin prevents HSC depletion, demonstrating
that aberrant mTORC1 activation is responsible for stem cell loss
(Chen et al., 2008; Gan et al., 2008; Ito et al., 2008; Yilmaz et al.,
2006). The negative effects of mTORC1 on HSC maintenance
have been attributed to its downstream targets in cell growth
pathways (Chen et al., 2008) and aberrant mTORC1 activity
elicits activation of tumor suppressive mechanisms that can
contribute to stem cell failure (Figure S6D) (Alimonti et al.,
2010; Lee et al., 2007a). By studying Plzf function in SPCs, we
now implicate negative feedback responses from the mTORC1
pathway to receptors required to transduce niche-derived self-
renewal signals in the loss of stem cell potential (Figure S6E).
HSC maintenance is also linked to niche signals acting
through growth factor receptors (Arai et al., 2004; Yoshihara
et al., 2007) thus it will be of interest to translate our findings
into the hematopoietic system. In addition, the decreased sensi-
tivity of Plzf / SPCs to GDNF mimics a reduced production of
niche-signals; the decline in stem cell numbers in aging mouse
testis is due partly to declining niche function and GDNF produc-
tion (Ryu et al., 2006; Zhang et al., 2006), thus loss of Plzf expres-
sion can represent a premature aging phenotype. Our studies
therefore provide further insight into the association between
stem cell maintenance, mTORC1, and aging (Harrison et al.,
2009; Rossi et al., 2008).
A correlation between aging and cancer is also apparent, likely
due to the accumulation of multiple genetic hits over time for
tumor development (Rossi et al., 2008). As stem cells are resi-
dent long-term in tissues and possess self-renewal capability
(a feature of cancer stem cells), they are suggested to be the
source of many cancers. However, loss of tumor suppressors
(e.g., Pten, Pml) trigger stem cell depletion (Ito et al., 2009) and
subsequent cancer development is associated with additional
genetic hits (Guo et al., 2008). It is proposed that oncogenicCell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc. 475
Figure 6. mTORC1 Inhibition Attenuates
SPC Maintenance Defect of Plzf / Mice
(A) Top panels: representative av-integrin/Thy-1
flow profiles of testis cells from Plzf +/+ and
Plzf / mice treated with vehicle or rapamycin
from 10 days postnatal age for a period of
1 week and analyzed the day after completing
treatment. Bottom panels: Flow cytometry anal-
ysis of c-Kit expression within the corresponding
av-integrin negative, Thy-1 low fractions.
(B) Quantification of frequency and absolute
numbers of av integrin negative, Thy-1 low, c-Kit
negative testis cells from mice of the indicated
genotypes treated with Vehicle or rapamycin as
in (A) (n R 5 per genotype and treatment group,
**p < 0.02, *p < 0.05). Graphs indicate mean
values ± SEM.
(C) WT juvenile mice (2–3 weeks postnatal) were
treated daily for 2weekswith rapamycin or vehicle.
Testes were harvested and subject to immunohis-
tochemistry for Plzf. Representative images are
203.
(D) Quantification of cells showing strong positivity
for Plzf in seminiferous tubules of testis from (C),
representing SPCs. Results from duplicate exper-
iments (1 and 2) are shown together with SEM
(**p < 0.01).
(E) Illustration of the effects of aberrant mTORC1
activity or inhibition of physiological mTORC1
activation with rapamycin on SPC numbers and
function.
See also Figure S6.hits in stem cells elicit activation of fail-safe mechanisms that
have to be evaded to allow cancer development (Figure S6D).
These fail-safe mechanisms prevent propagation of clones of
cells derived from stem cells with oncogenic mutations and the
consequent risk of acquiring additional mutations that lead to
cancer. The mTORC1 hyperactivation that occurs in response
to loss of tumor suppressors such as Pten and Pml is likely
a trigger of this fail-safe mechanism as rapamycin prevents
stem cell exhaustion. Based on our new model, mTORC1
hyperactivation in response to oncogenic stimulation may also
desensitize the cancer stem cell to niche-signals that are
required for self-renewal; thus additional mutations supporting
niche-independent self-renewal could allow cancer to develop
(Figure S6E).476 Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc.PLZF was first identified from involve-
ment in acute promyelocytic leukemia
(APL) (Chen et al., 1993). Thus, our model
of Plzf-dependent SPC maintenance
can have implications for leukemia patho-
genesis. The ability of Plzf to inhibit
mTORC1 through Redd1 induction may
be relevant in this context given that
perturbed PLZF function and elevated
mTORC1 activity are associated with
leukemia development (He et al., 2000;
Martelli et al., 2007; McConnell and Licht,
2007). In addition, REDD1 is involved inleukemic and myeloid cell differentiation (Gery et al., 2007;
Nishioka et al., 2009), suggesting that this gene can be a
relevant PLZF target in hematopoietic cells. PML, also identified
from its involvement in chromosomal translocations with the
RARA gene in APL, is required for HSCmaintenance and inhibits
mTORC1 (Bernardi et al., 2006; Ito et al., 2008); thus illustrating
a striking commonality of function between the RARA partners
of APL.
We have identified a role for Plzf-mediated Redd1 expression
in inhibiting mTORC1 activation in SPCs. As mTORC1 activity
has a significant impact on the response of SPCs to GDNF, the
tight regulation of this pathway is critical. Redd1 is also induced
in response to cellular stress and in particular, by hypoxia
(Brugarolas et al., 2004; Shoshani et al., 2002). Interestingly,
the HSC niche has been suggested to exist in a hypoxic state
(Kubota et al., 2008; Parmar et al., 2007) that, if the SPC niche
had similar characteristics, could be responsible for Redd1
induction. However, SPCs reside close to the vasculature
in vivo (Yoshida et al., 2007) andRedd1 expression is maintained
when SPCs are cultured at atmospheric oxygen levels. Thus
Redd1 expression in this case depends on a Plzf tonic transcrip-
tional activity and its induction is seemingly independent of
hypoxia.
As mTORC1 inhibition enhances SPC function even in a WT
setting, our data also have important therapeutic implications.
It is tempting to speculate that rapamycin could be used to
enhance SPC activity in humans; potentially allowing improved
SPC culture from testicular biopsies and generation of therapeu-
tically relevant MASCs (Figure 6E). Furthermore, our findings
provide a novel and straightforward explanation for the require-
ment of Plzf in germline maintenance.
EXPERIMENTAL PROCEDURES
Mouse Maintenance and Manipulation
Plzf /mice are previously described (Costoya et al., 2004). Mice were treated
with rapamycin (LC Laboratories) at a daily dose of 4 mg/kg as described
(Yilmaz et al., 2006). Transgenic mice expressing EGFP from the b-actin
promoter were from Jackson Laboratories. Testis transplant assays were
performed as described (Seandel et al., 2007) with 50 3 103 unfractionated
or 5 3 103 avneg Thy-1low c-Kitneg testis cells injected per recipient testis.
Teratoma formation assays in NOD/SCID mice (Jackson Laboratories) were
performed as described (Seandel et al., 2007).Antibody Generation
Monoclonal anti-PLZF antibody (clone 9E12) was raised in Armenian hamster
against a pool of keyhole limpet hemocyanin (KLH)-conjugated peptides at the
Memorial Sloan-Kettering Cancer Center (MSKCC) antibody facility and reacts
to a peptide within the hinge domain of mouse Plzf (RSKEGPGTPTRRSVIT
SARE). Antibody was directly conjugated to Alexa 488 or Alexa 647 for use
in flow cytometry (MSKCC antibody facility).Flow Cytometry
Single cell suspensions were prepared from testis as described (Ogawa et al.,
1997) and resuspended in phosphate-buffered saline (PBS) containing 2%
fetal bovine serum (FBS) for subsequent staining and analysis (Filipponi
et al., 2007). For a detailed description of flow cytometry methods and anti-
bodies used, refer to the Extended Experimental Procedures.Cell Culture and Treatment
SPC fractions from testis were plated directly onto mitotically inactivated MEF
feeder cells. Medium for SPC culture was as previously described (Seandel
et al., 2007) supplemented with 10 ng/ml IGF-I (Peprotech). MASCs and
mouse ESCs (v6.5) were cultured in embryonic stem cell medium on MEF
feeders (Seandel et al., 2007). Knockdown of Redd1 expression in SPCs by
shRNA was performed using pLKO.1 lentiviral vectors (Open Biosystems).
A detailed description of methods is included in the Extended Experimental
Procedures.Immunofluorescence, Immunohistochemistry, and Western Blot
Tissue and cultured cells were fixed in 4% paraformaldehyde before
processing for immunofluorescence (IF) and immunohistochemistry (IHC) as
described (Costoya et al., 2004; Filipponi et al., 2007). For western blot anal-
ysis, cells were lysed in RIPA buffer and processed as described (Costoya
et al., 2008). Detailed methods are included in the Extended Experimental
Procedures.Chromatin Immunoprecipitation (ChIP)
SPCs were trypsinized and resuspended in SPC medium then incubated in
tissue culture dishes for 30 min to remove contaminating (adherent) MEFs.
Preparation and immunoprecipitation of chromatin was performed using
a SimpleChIP Enzymatic Chromatin IP kit (Cell Signaling Technology)
according to manufacturers instructions and monoclonal anti-PLZF antibody
(Calbiochem). DNA samples were analyzed by quantitative PCR using a
QuantiTect SYBR Green PCR kit (QIAGEN) and Light Cycler (Roche). Primer
sequences for the Redd1 promoter are included in the Extended Experimental
Procedures.
Luciferase Assay
REDD1 promoter constructs are described (Lin et al., 2005) and were cloned
from U2OS genomic DNA into the pGL3-enhancer vector (Promega). Lucif-
erase assays were performed with 293HEK cells as described (Barna et al.,
2002). Please refer to Extended Experimental Procedures for details.
Quantitative Reverse Transcription Polymerase Chain Reaction
(qRT-PCR)
RNA was harvested using Trizol reagent (Invitrogen) then used for first strand
cDNA synthesis and subsequent quantitative PCR analysis as described
(Filipponi et al., 2007). For primer sequences and detailed methodology please
see Extended Experimental Procedures.
Statistical Analysis
Results from cell growth assays, testis transplants, and flow cytometry anal-
ysis were assessed for statistical significance by a standard two-tailed t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at doi:10.1016/j.cell.
2010.06.041.
ACKNOWLEDGMENTS
We thank current and past members of the Pandolfi lab and in particular Taka-
hiro Maeda and Rosa Bernardi for helpful discussion and advice. We would
also like to thank Antonella Papa for generating luciferase reporters, Sharmila
Fagoonee for experimental help, Leif Ellisen for Redd1 promoter constructs,
and the flow cytometry facilities of BIDMC and MSKCC for expert support.
M.S. is a Stanley and Fiona Druckenmiller Fellow of the New York Stem Cell
Foundation. This work was supported by NIH grants to P.P.P.
Received: October 5, 2009
Revised: April 1, 2010
Accepted: May 28, 2010
Published: August 5, 2010
REFERENCES
Alimonti, A., Nardella, C., Chen, Z., Clohessy, J.G., Carracedo, A., Trotman,
L.C., Cheng, K., Varmeh, S., Kozma, S.C., Thomas, G., et al. (2010). A novel
type of cellular senescence that can be enhanced inmousemodels and human
tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 120,
681–693.
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh,
G.Y., and Suda, T. (2004). Tie2/angiopoietin-1 signaling regulates hematopoi-
etic stem cell quiescence in the bone marrow niche. Cell 118, 149–161.
Barna, M., Merghoub, T., Costoya, J.A., Ruggero, D., Branford, M., Bergia, A.,
Samori, B., and Pandolfi, P.P. (2002). Plzf mediates transcriptional repression
of HoxD gene expression through chromatin remodeling. Dev. Cell 3, 499–510.
Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya-Feldstein, J.,
Cordon-Cardo, C., Simon, M.C., Rafii, S., and Pandolfi, P.P. (2006). PML
inhibits HIF-1alpha translation and neoangiogenesis through repression of
mTOR. Nature 442, 779–785.Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc. 477
Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane,W.S., and
Schreiber, S.L. (1994). Amammalian protein targeted by G1-arresting rapamy-
cin-receptor complex. Nature 369, 756–758.
Brugarolas, J., Lei, K., Hurley, R.L., Manning, B.D., Reiling, J.H., Hafen, E.,
Witters, L.A., Ellisen, L.W., and Kaelin, W.G., Jr. (2004). Regulation of mTOR
function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor
suppressor complex. Genes Dev. 18, 2893–2904.
Buaas, F.W., Kirsh, A.L., Sharma, M., McLean, D.J., Morris, J.L., Griswold,
M.D., de Rooij, D.G., and Braun, R.E. (2004). Plzf is required in adult male
germ cells for stem cell self-renewal. Nat. Genet. 36, 647–652.
Castilho, R.M., Squarize, C.H., Chodosh, L.A., Williams, B.O., and Gutkind,
J.S. (2009). mTOR mediates Wnt-induced epidermal stem cell exhaustion
and aging. Cell Stem Cell 5, 279–289.
Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.L., and Zheng, P. (2008). TSC-
mTOR maintains quiescence and function of hematopoietic stem cells by
repressing mitochondrial biogenesis and reactive oxygen species. J. Exp.
Med. 205, 2397–2408.
Chen, Z., Brand, N.J., Chen, A., Chen, S.J., Tong, J.H., Wang, Z.Y., Waxman,
S., and Zelent, A. (1993). Fusion between a novel Kruppel-like zinc finger gene
and the retinoic acid receptor-alpha locus due to a variant t(11;17) transloca-
tion associated with acute promyelocytic leukaemia. EMBO J. 12, 1161–1167.
Corradetti, M.N., Inoki, K., and Guan, K.L. (2005). The stress-inducted proteins
RTP801 and RTP801L are negative regulators of the mammalian target of
rapamycin pathway. J. Biol. Chem. 280, 9769–9772.
Costoya, J.A., Hobbs, R.M., Barna, M., Cattoretti, G., Manova, K., Sukhwani,
M., Orwig, K.E., Wolgemuth, D.J., and Pandolfi, P.P. (2004). Essential role of
Plzf in maintenance of spermatogonial stem cells. Nat. Genet. 36, 653–659.
Costoya, J.A., Hobbs, R.M., and Pandolfi, P.P. (2008). Cyclin-dependent
kinase antagonizes promyelocytic leukemia zinc-finger through phosphoryla-
tion. Oncogene 27, 3789–3796.
David, G., Alland, L., Hong, S.H., Wong, C.W., DePinho, R.A., and Dejean, A.
(1998). Histone deacetylase associated with mSin3A mediates repression by
the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16,
2549–2556.
de Rooij, D.G., and Russell, L.D. (2000). All you wanted to know about
spermatogonia but were afraid to ask. J. Androl. 21, 776–798.
Doulatov, S., Notta, F., Rice, K.L., Howell, L., Zelent, A., Licht, J.D., and Dick,
J.E. (2009). PLZF is a regulator of homeostatic and cytokine-induced myeloid
development. Genes Dev. 23, 2076–2087.
Ellisen, L.W., Ramsayer, K.D., Johannessen, C.M., Yang, A., Beppu, H.,
Minda, K., Oliner, J.D.,McKeon, F., andHaber, D.A. (2002). REDD1, a develop-
mentally regulated transcriptional target of p63 and p53, links p63 to regulation
of reactive oxygen species. Mol. Cell 10, 995–1005.
Encinas, M., Tansey, M.G., Tsui-Pierchala, B.A., Comella, J.X., Milbrandt, J.,
and Johnson, E.M., Jr. (2001). c-Src is required for glial cell line-derived neuro-
trophic factor (GDNF) family ligand-mediated neuronal survival via a phospha-
tidylinositol-3 kinase (PI-3K)-dependent pathway. J. Neurosci. 21, 1464–1472.
Fan, Q.W., Cheng, C., Knight, Z.A., Haas-Kogan, D., Stokoe, D., James, C.D.,
McCormick, F., Shokat, K.M., and Weiss, W.A. (2009). EGFR signals to mTOR
through PKC and independently of Akt in glioma. Sci. Signal. 2, ra4.
Filipponi, D., Hobbs, R.M., Ottolenghi, S., Rossi, P., Jannini, E.A., Pandolfi,
P.P., and Dolci, S. (2007). Repression of kit expression by Plzf in germ cells.
Mol. Cell. Biol. 27, 6770–6781.
Fingar, D.C., Salama, S., Tsou, C., Harlow, E., and Blenis, J. (2002). Mamma-
lian cell size is controlled by mTOR and its downstream targets S6K1 and
4EBP1/eIF4E. Genes Dev. 16, 1472–1487.
Fischer, S., Kohlhase, J., Bohm, D., Schweiger, B., Hoffmann, D., Heitmann,
M., Horsthemke, B., and Wieczorek, D. (2008). Biallelic loss of function of
the promyelocytic leukemia zinc finger (PLZF) gene causes severe skeletal
defects and genital hypoplasia. J. Med. Genet. 45, 731–737.
Gan, B., and DePinho, R.A. (2009). mTORC1 signaling governs hematopoietic
stem cell quiescence. Cell Cycle 8, 1003–1006.478 Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc.Gan, B., Sahin, E., Jiang, S., Sanchez-Aguilera, A., Scott, K.L., Chin, L.,
Williams, D.A., Kwiatkowski, D.J., and DePinho, R.A. (2008). mTORC1-depen-
dent and -independent regulation of stem cell renewal, differentiation, and
mobilization. Proc. Natl. Acad. Sci. USA 105, 19384–19389.
Gery, S., Park, D.J., Vuong, P.T., Virk, R.K., Muller, C.I., Hofmann, W.K., and
Koeffler, H.P. (2007). RTP801 is a novel retinoic acid-responsive gene associ-
ated with myeloid differentiation. Exp. Hematol. 35, 572–578.
Guo, W., Lasky, J.L., Chang, C.J., Mosessian, S., Lewis, X., Xiao, Y., Yeh, J.E.,
Chen, J.Y., Iruela-Arispe, M.L., Varella-Garcia, M., et al. (2008). Multi-genetic
events collaboratively contribute to Pten-null leukemia stem-cell formation.
Nature 453, 529–533.
Hamra, F.K., Chapman, K.M., Nguyen, D., and Garbers, D.L. (2007). Identifica-
tion of neuregulin as a factor required for formation of aligned spermatogonia.
J. Biol. Chem. 282, 721–730.
Harrington, L.S., Findlay, G.M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz,
H., Barnett, J., Leslie, N.R., Cheng, S., Shepherd, P.R., et al. (2004). The
TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of
IRS proteins. J. Cell Biol. 166, 213–223.
Harrington, L.S., Findlay, G.M., and Lamb, R.F. (2005). Restraining PI3K:
mTOR signalling goes back to themembrane. Trends Biochem. Sci. 30, 35–42.
Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K.,
Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S., et al. (2009). Rapamycin
fed late in life extends lifespan in genetically heterogeneous mice. Nature 460,
392–395.
He, L.Z., Bhaumik, M., Tribioli, C., Rego, E.M., Ivins, S., Zelent, A., and
Pandolfi, P.P. (2000). Two critical hits for promyelocytic leukemia. Mol. Cell
6, 1131–1141.
Hennige, A.M., Lammers, R., Arlt, D., Hoppner, W., Strack, V., Niederfellner,
G., Seif, F.J., Haring, H.U., and Kellerer, M. (2000). Ret oncogene signal trans-
duction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway:
possible implication for transforming activity in NIH3T3 cells. Mol. Cell. Endo-
crinol. 167, 69–76.
Huang, J., and Manning, B.D. (2008). The TSC1-TSC2 complex: a molecular
switchboard controlling cell growth. Biochem. J. 412, 179–190.
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G., Ikeda, Y., Rosenblatt,
J., Avigan, D.E., Teruya-Feldstein, J., and Pandolfi, P.P. (2008). PML targeting
eradicates quiescent leukaemia-initiating cells. Nature 453, 1072–1078.
Ito, K., Bernardi, R., and Pandolfi, P.P. (2009). A novel signaling network as
a critical rheostat for the biology and maintenance of the normal stem cell
and the cancer-initiating cell. Curr. Opin. Genet. Dev. 19, 51–59.
Kanatsu-Shinohara, M., Inoue, K., Lee, J., Yoshimoto, M., Ogonuki, N., Miki,
H., Baba, S., Kato, T., Kazuki, Y., Toyokuni, S., et al. (2004a). Generation of
pluripotent stem cells from neonatal mouse testis. Cell 119, 1001–1012.
Kanatsu-Shinohara, M., Ogonuki, N., Inoue, K., Miki, H., Ogura, A., Toyokuni,
S., and Shinohara, T. (2003). Long-term proliferation in culture and germline
transmission of mouse male germline stem cells. Biol. Reprod. 69, 612–616.
Kanatsu-Shinohara, M., Toyokuni, S., and Shinohara, T. (2004b). CD9 is
a surface marker on mouse and rat male germline stem cells. Biol. Reprod.
70, 70–75.
Kubota, H., Avarbock, M.R., and Brinster, R.L. (2003). Spermatogonial stem
cells share some, but not all, phenotypic and functional characteristics with
other stem cells. Proc. Natl. Acad. Sci. USA 100, 6487–6492.
Kubota, H., Avarbock, M.R., and Brinster, R.L. (2004). Growth factors essential
for self-renewal and expansion of mouse spermatogonial stem cells. Proc.
Natl. Acad. Sci. USA 101, 16489–16494.
Kubota, Y., Takubo, K., and Suda, T. (2008). Bone marrow long label-retaining
cells reside in the sinusoidal hypoxic niche. Biochem. Biophys. Res. Commun.
366, 335–339.
Labbaye, C., Quaranta, M.T., Pagliuca, A., Militi, S., Licht, J.D., Testa, U., and
Peschle, C. (2002). PLZF induces megakaryocytic development, activates
Tpo receptor expression and interacts with GATA1 protein. Oncogene 21,
6669–6679.
Lee, C.H., Inoki, K., Karbowniczek,M., Petroulakis, E., Sonenberg, N., Henske,
E.P., and Guan, K.L. (2007a). Constitutive mTOR activation in TSC mutants
sensitizes cells to energy starvation and genomic damage via p53. EMBO J.
26, 4812–4823.
Lee, J., Kanatsu-Shinohara, M., Inoue, K., Ogonuki, N., Miki, H., Toyokuni, S.,
Kimura, T., Nakano, T., Ogura, A., and Shinohara, T. (2007b). Akt mediates
self-renewal division of mouse spermatogonial stem cells. Development
134, 1853–1859.
Lin, L., Stringfield, T.M., Shi, X., and Chen, Y. (2005). Arsenite induces a cell
stress-response gene, RTP801, through reactive oxygen species and tran-
scription factors Elk-1 and CCAAT/enhancer-binding protein. Biochem. J.
392, 93–102.
Ma, X.M., and Blenis, J. (2009). Molecular mechanisms of mTOR-mediated
translational control. Nat. Rev. Mol. Cell Biol. 10, 307–318.
Martelli, A.M., Tazzari, P.L., Evangelisti, C., Chiarini, F., Blalock, W.L., Billi,
A.M., Manzoli, L., McCubrey, J.A., and Cocco, L. (2007). Targeting the phos-
phatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for
acute myelogenous leukemia therapy: from bench to bedside. Curr. Med.
Chem. 14, 2009–2023.
McConnell, M.J., and Licht, J.D. (2007). The PLZF gene of t (11;17)-associated
APL. Curr. Top. Microbiol. Immunol. 313, 31–48.
Meng, X., Lindahl, M., Hyvonen, M.E., Parvinen, M., de Rooij, D.G., Hess,
M.W., Raatikainen-Ahokas, A., Sainio, K., Rauvala, H., Lakso, M., et al.
(2000). Regulation of cell fate decision of undifferentiated spermatogonia by
GDNF. Science 287, 1489–1493.
Nagano, M., Avarbock, M.R., and Brinster, R.L. (1999). Pattern and kinetics of
mouse donor spermatogonial stem cell colonization in recipient testes. Biol.
Reprod. 60, 1429–1436.
Nishioka, C., Ikezoe, T., Yang, J., Gery, S., Koeffler, H.P., and Yokoyama, A.
(2009). Inhibition of mammalian target of rapamycin signaling potentiates the
effects of all-trans retinoic acid to induce growth arrest and differentiation of
human acute myelogenous leukemia cells. Int. J. Cancer 125, 1710–1720.
Oatley, J.M., Avarbock, M.R., and Brinster, R.L. (2007). Glial cell line-derived
neurotrophic factor regulation of genes essential for self-renewal of mouse
spermatogonial stem cells is dependent on Src family kinase signaling. J.
Biol. Chem. 282, 25842–25851.
Oatley, J.M., Avarbock, M.R., Telaranta, A.I., Fearon, D.T., and Brinster, R.L.
(2006). Identifying genes important for spermatogonial stem cell self-renewal
and survival. Proc. Natl. Acad. Sci. USA 103, 9524–9529.
Ogawa, T., Arechaga, J.M., Avarbock, M.R., and Brinster, R.L. (1997). Trans-
plantation of testis germinal cells into mouse seminiferous tubules. Int. J. Dev.
Biol. 41, 111–122.
Ohbo, K., Yoshida, S., Ohmura, M., Ohneda, O., Ogawa, T., Tsuchiya, H.,
Kuwana, T., Kehler, J., Abe, K., Scholer, H.R., et al. (2003). Identification and
characterization of stem cells in prepubertal spermatogenesis in mice small
star, filled. Dev. Biol. 258, 209–225.
Parmar, K., Mauch, P., Vergilio, J.A., Sackstein, R., and Down, J.D. (2007).
Distribution of hematopoietic stem cells in the bone marrow according to
regional hypoxia. Proc. Natl. Acad. Sci. USA 104, 5431–5436.
Rossi, D.J., Jamieson, C.H., and Weissman, I.L. (2008). Stems cells and the
pathways to aging and cancer. Cell 132, 681–696.
Ruvinsky, I., Sharon, N., Lerer, T., Cohen, H., Stolovich-Rain, M., Nir, T., Dor,
Y., Zisman, P., andMeyuhas, O. (2005). Ribosomal protein S6 phosphorylation
is a determinant of cell size and glucose homeostasis. Genes Dev. 19,
2199–2211.
Ryu, B.Y., Orwig, K.E., Oatley, J.M., Avarbock, M.R., and Brinster, R.L. (2006).
Effects of aging and niche microenvironment on spermatogonial stem cell
self-renewal. Stem Cells 24, 1505–1511.Schieke, S.M., and Finkel, T. (2006). Mitochondrial signaling, TOR, and life
span. Biol. Chem. 387, 1357–1361.
Schrans-Stassen, B.H., van de Kant, H.J., de Rooij, D.G., and van Pelt, A.M.
(1999). Differential expression of c-kit in mouse undifferentiated and differen-
tiating type A spermatogonia. Endocrinology 140, 5894–5900.
Seandel, M., James, D., Shmelkov, S.V., Falciatori, I., Kim, J., Chavala, S.,
Scherr, D.S., Zhang, F., Torres, R., Gale, N.W., et al. (2007). Generation of
functional multipotent adult stem cells from GPR125+ germline progenitors.
Nature 449, 346–350.
Shah, O.J., Wang, Z., and Hunter, T. (2004). Inappropriate activation of the
TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance,
and cell survival deficiencies. Curr. Biol. 14, 1650–1656.
Shaw, R.J., and Cantley, L.C. (2006). Ras, PI(3)K andmTOR signalling controls
tumour cell growth. Nature 441, 424–430.
Shinohara, T., Avarbock, M.R., and Brinster, R.L. (1999). beta1- and alpha6-
integrin are surface markers on mouse spermatogonial stem cells. Proc.
Natl. Acad. Sci. USA 96, 5504–5509.
Shinohara, T., Orwig, K.E., Avarbock, M.R., and Brinster, R.L. (2000).
Spermatogonial stem cell enrichment by multiparameter selection of mouse
testis cells. Proc. Natl. Acad. Sci. USA 97, 8346–8351.
Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y.,
Elbaz, S., Budanov, A., Chajut, A., et al. (2002). Identification of a novel
hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.
Mol. Cell. Biol. 22, 2283–2293.
Takubo, K., Ohmura, M., Azuma, M., Nagamatsu, G., Yamada, W., Arai, F.,
Hirao, A., and Suda, T. (2008). Stem cell defects in ATM-deficient undifferen-
tiated spermatogonia through DNA damage-induced cell-cycle arrest. Cell
Stem Cell 2, 170–182.
Virtanen, I., Kallajoki, M., Narvanen, O., Paranko, J., Thornell, L.E., Miettinen,
M., and Lehto, V.P. (1986). Peritubular myoid cells of human and rat testis
are smooth muscle cells that contain desmin-type intermediate filaments.
Anat. Rec. 215, 10–20.
Wu, X., Oatley, J.M., Oatley,M.J., Kaucher, A.V., Avarbock,M.R., andBrinster,
R.L. (2010). The POU domain transcription factor POU3F1 is an important
intrinsic regulator of GDNF-induced survival and self-renewal of mouse
spermatogonial stem cells. Biol. Reprod. 82, 1103–1111.
Yilmaz, O.H., Valdez, R., Theisen, B.K., Guo, W., Ferguson, D.O., Wu, H., and
Morrison, S.J. (2006). Pten dependence distinguishes hematopoietic stem
cells from leukemia-initiating cells. Nature 441, 475–482.
Yoshida, S., Sukeno, M., and Nabeshima, Y. (2007). A vasculature-associated
niche for undifferentiated spermatogonia in the mouse testis. Science 317,
1722–1726.
Yoshida, S., Sukeno, M., Nakagawa, T., Ohbo, K., Nagamatsu, G., Suda, T.,
and Nabeshima, Y. (2006). The first round of mouse spermatogenesis is
a distinctive program that lacks the self-renewing spermatogonia stage.
Development 133, 1495–1505.
Yoshihara, H., Arai, F., Hosokawa, K., Hagiwara, T., Takubo, K., Nakamura, Y.,
Gomei, Y., Iwasaki, H., Matsuoka, S., Miyamoto, K., et al. (2007). Thrombo-
poietin/MPL signaling regulates hematopoietic stem cell quiescence and
interaction with the osteoblastic niche. Cell Stem Cell 1, 685–697.
Zhang, H., Bajraszewski, N., Wu, E., Wang, H., Moseman, A.P., Dabora, S.L.,
Griffin, J.D., and Kwiatkowski, D.J. (2007). PDGFRs are critical for PI3K/Akt
activation and negatively regulated by mTOR. J. Clin. Invest. 117, 730–738.
Zhang, X., Ebata, K.T., Robaire, B., and Nagano, M.C. (2006). Aging of male
germ line stem cells in mice. Biol. Reprod. 74, 119–124.Cell 142, 468–479, August 6, 2010 ª2010 Elsevier Inc. 479
